Intraocular Lens (IOL) Market Size, Share, Regional Growth, 2026-2034

Market Overview

According to fortune business insights, The global intraocular lens (IOL) market size was valued at USD 5.14 billion in 2025. The market is projected to grow from USD 5.49 billion in 2026 to USD 9.52 billion by 2034, exhibiting a CAGR of 7.13% during the forecast period. North America dominated the intraocular lens market with a market share of 33.76% in 2025.

The analysis shows that intraocular lenses—artificial lenses implanted in the eye during cataract and glaucoma surgeries—are experiencing strong demand due to the rising global prevalence of cataracts. According to the WHO, an estimated 94.0 million people suffer from cataracts globally, with a massive unmet need for surgical intervention. Advanced product launches, coupled with rising government support and favorable reimbursement policies to decrease surgery backlogs, are significantly contributing to market growth.

Major Players Profiled in the Market Report:

• Alcon Inc. (Switzerland)

• Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc. (U.S.)

• Bausch & Lomb Incorporated (Canada)

• HOYA (Japan)

• STAAR SURGICAL (U.S.)

• Rayner Intraocular Lenses Limited. (U.K.)

• Hanita Lenses (Israel)

• SIFI S.p.A (Italy)

• Biotech (Switzerland)

Segments

Affordability of Monofocal Lenses Boosted Segment Growth

Based on type, the market is segmented into monofocal and premium (multifocal, toric, and others). The monofocal segment holds the dominant market share (projected at 64.41% in 2026). This is because monofocal lenses are cheaper than premium alternatives, widely used in government-led cataract surgery initiatives, and benefit from more favorable reimbursement policies.

High Demand for Hydrophobic Acrylic Products Favors the Foldable Segment’s Dominance

By material, the market is divided into polymethylmethacrylate (PMMA) and foldable (hydrophobic acrylic, hydrophilic acrylic, and silicone & collamer). The foldable segment is dominating the market with a projected share of 87.59% in 2026 due to its high refractive index, low water content, and ability to be inserted through small surgical incisions.

Favorable Government Policies to Drive the Growth of Hospitals & Ambulatory Surgery Centers

Based on end-user, the market is segmented into hospitals & ambulatory surgery centers, specialty clinics, and academic & research institutes. The hospitals & ambulatory surgery centers segment dominates the market (projected at 57.42% in 2026) as they are the primary care centers for cataract procedures, supported by special government drives to clear surgery backlogs.

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Report Coverage

The report offers:

• Detailed market overview highlighting vital aspects such as market dynamics, type, material, end-user, and geography.

• Comprehensive insights into the regulatory and reimbursement scenarios, prevalence of cataracts, and number of surgeries.

• Overview of government cataract initiatives and the COVID-19 pandemic's effect on the market.

• Key industry developments such as mergers, acquisitions, partnerships, and new product launches.

• Numerous factors contributing to the market's growth and industry trends.

Source: https://www.fortunebusinessinsights.com/industry-reports/intraocular-lens-market-101220

Drivers & Restraints

Increase in Cataract Surgeries and Launch of Government Initiatives to Propel Market Growth

The increasing global geriatric population has led to a surge in age-related cataracts, driving massive demand for surgical procedures. Governments worldwide are launching significant initiatives (such as Vision 2020 globally and the Netra Jyoti Abhiyan in India) to eliminate avoidable blindness and clear surgery backlogs. Furthermore, the introduction of technologically advanced products, such as extended depth of focus (EDOF) lenses, is boosting market expansion.

However, the absence of adequate reimbursement policies for high-end/premium products (which address complex issues like astigmatism and presbyopia) in both developed and developing countries poses a significant barrier to market growth and limits the widespread adoption of advanced IOLs.

Regional Insights

High Demand for Novel Products Propels Market Growth in North America

North America holds the dominant intraocular lens market share (33.76% in 2025, valued at USD 1.74 billion) and is projected to experience continued growth. The region’s dominance is attributed to rapid adoption of advanced technologies, substantial demand for custom cataract lenses, and the presence of favorable insurance policies.

Asia Pacific (29.07% share in 2025) and Europe (28.88% share in 2025) are also key regions. Europe's growth is propelled by a high prevalence of age-related eye conditions (an estimated 64.0% of the population over 70 has cataracts). Meanwhile, the Asia Pacific region is expanding rapidly due to a booming geriatric population and an increasing number of patients seeking advanced treatment options in countries like Japan, China, and India.

Intraocular Lens (IOL) Market Future Growth:

The intraocular lens market is poised for robust future growth, largely driven by shifting global demographics and an aging population highly susceptible to cataracts. As governments and health organizations intensify campaigns to eradicate preventable blindness, surgical volumes will continue to soar. The market will see a strong shift toward premiumization as manufacturers innovate with next-generation materials and extended depth of focus (EDOF) technologies, offering patients enhanced visual acuity and lifestyle improvements. To fully unlock this potential, industry players will likely focus on strategic partnerships and advocating for broader health insurance coverage to make premium lenses more accessible to the general public.

Competitive Landscape

Robust Product Launches and Global Presence of Top Players to Lead the Market

The intraocular lens market represents a consolidated structure dominated by major players like Alcon Inc. and Johnson & Johnson Vision Care. These leading companies maintain their peak market positions through robust product portfolios (such as Alcon's ACRYSOF and J&J's Tecnis), strong geographical footprints, and widespread distribution networks. Their competitive strategies heavily revolve around launching technologically advanced lenses and securing strategic mergers, acquisitions, and distributor partnerships to capture a higher market share globally.

Key Industry Developments

• November 2023: Ophtec launched a hybrid acrylic IOL named Precizon Go to provide distance and enhanced intermediate vision.

• October 2023: Bausch & Lomb Incorporated announced the launch of enVista Aspire monofocal and toric intraocular lenses (IOLs) in the U.S. market.